No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Induction chemotherapy may improve survival in patients with esophageal adenocarcinoma

byTeddy Guo

November 8, 2021

in StudyGraphics

Reading Time: 1 min read

#VisualAbstract: Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response

RelatedReports

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Chronic Disease

Septoplasty is more costly but more effective than medical management for deviated septum

July 13, 2026

Benefits of high-intensity surveillance following colorectal adenoma removal likely outweigh costs

Chronic Disease

The incidence of early-onset metastatic adenocarcinoma may be higher among patients with multiple metastatic sites and peritoneal involvement

April 30, 2026

Hybrid minimally invasive esophagectomy associated with lower complication rates compared to open esophagectomy

Chronic Disease

Camrelizumab may be safe and effective in the management of locally advanced esophageal squamous cell carcinoma

March 19, 2026

Bilateral diagonal earlobe creases associated with increased risk of coronary artery disease

Chronic Disease

Short-course personalized acoustic therapy may increase tinnitus remission in patients with idiopathic sudden sensorineural hearing loss

January 13, 2026

Ultrasound enhances gastrointestinal absorption of drugs at low frequencies

7-day antibiotic therapy is noninferior to 14-day therapy in afebrile men with urinary tract infection

Sleep duration inversely related to childhood type 2 diabetes risk makers

Association between BMI and diabetes risk among low-middle income countries varies considerably by geographical region

Government-funded initiatives provide important supports to low-income HIV patients

Targeted screening not superior to nontargeted screening for human immunodeficiency virus in the emergency department

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract: Induction chemotherapy may improve survival in patients with esophageal adenocarcinoma

RELATED REPORTS

#VisualAbstract: Mixed vaccination with ChAdOx1-S followed by BNT162b2 induces a robust humoral immune response

7-day antibiotic therapy is noninferior to 14-day therapy in afebrile men with urinary tract infection

RelatedReports

Recent Reports